NextCure, an emerging global leader in developing novel immunomedicines to treat cancer and other immune-related diseases, was recently featured on Prince George’s County Economic Development Corporation’s (PGCEDC) Business Spotlight video series.
Over a period of four days, life sciences companies from across the globe will descend on San Diego for the annual Biotechnology Innovation Organization (BIO) meeting. Multiple companies from Maryland, as well as the Department of Commerce, will be among them, showcasing the strength of the BioHealth Capital Region.
NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today reported first quarter 2022 financial results and provided a business update.
BioBuzz recently spoke with Shannon Biermann, who is a Senior Quality Control Manager of Microbiology at Beltsville, MD-based NextCure, to learn more about how she’s navigated her career in Microbiology QC thus far and how NextCure’s unique company culture helped her to take ownership and propel her career to the next level.
It’s an age-old thinking that the arts and sciences mix as well as oil and water, with artists being stereotyped as whimsical, quirky, and creative, and scientists as analytical, awkward, and calculating. Folks who use the acronym “STEAM” instead of “STEM”, which accounts for the addition of “Art”, are often met with criticism from folks who think that the arts are not technically rigorous enough to warrant inclusion.
WorkForce Genetics recently hosted the webinar event, “Navigating Your Biomanufacturing Career.” The webinar, which was held in March 2022, brought together industry thought leaders for a robust panel discussion about biomanufacturing career tips for the BioHealth Capital Region’s booming job market.
The biotech economy continues its expansion and shows no sign of slowing in 2022. On this webinar you’ll hear from several biomanufacturing leaders from various sectors of the field to talk about the biomanufacturing roles at their company and what they look for when hiring for their teams.
FREDERICK, Md.–(BUSINESS WIRE)–The Maryland Tech Council is proud to announce the finalists for its annual Industry Awards Celebration. The event honors individuals and companies in the life sciences, technology, and government contracting industries that have made a significant impact in their respective fields. For the first time in two years, the awards ceremony will be held in person, with the winners announced live on May 12th at the Bethesda North Marriott Hotel & Conference Center. Last year over 9,000 people tuned in to the virtual Industry Awards Celebration. Click here to learn more about the event.
“We are thrilled to be returning in person for this year’s Industry Awards. It’s a terrific opportunity to recognize our colleagues for their contributions over the past year, and there is no substitute for live events,” said IAC committee Co-Chair and Business Development Leader, Atlantic Region at BDO, Tony DeFlumeri.
The BHCR cluster, in particular, includes a host of emerging and established cell and gene therapy companies, as well one of the deepest and most advanced biomanufacturing infrastructures in the U.S. While the cell and gene therapy industry still faces challenges like high manufacturing costs, high cost per dose to patients and complex supply chain issues, this sector remains very healthy and is continuing to grow rapidly in our region and globally.
Cell therapies have grown to become a prevailing field dominating new medical breakthroughs with the promise of treatments and cures for multiple diseases. The biopharma hubs of Philadelphia and Maryland have emerged as important drivers of this new wave of medicine, build on the foundation of renowned research institutes, universities, and a number of successful cell therapy companies who have paved the way forward in this field.